One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial.

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble ... to market its drug for obesity more than two years before Eli Lilly. But Novo Nordisk has been rapidly losing ...

Diet and exercise tend to benefit men much more than women when it comes ... that may have implications for the treatment of women before or after menopause, since estrogen levels fall in women ...

explained that the Wegovy pill is vulnerable to enzymatic breakdown in the stomach. “This means that patients will need to take the medication on an empty stomach, at least 30 minutes before a ...

Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial ... using tirzepatide lost more weight after 72 weeks (average loss of 20.2% ...

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...